论文部分内容阅读
目的:探讨低分子肝素钠治疗重度子痫前期的临床疗效.方法:回顾性2010年5月~2012年4月来我院妇产科诊断和治疗的重度子痫前期患者80例,随机将80例患者分为两组各40例.治疗组采用低分子肝素钠5000u腹壁皮下注射;对照组采用常规治疗重度子痫前期方法.对比两组治疗前后血压、尿量、24小时尿蛋白定量、孕周延长时间、凝血功能、血小板计数及产后出血量,评价两组围产儿结局及并发症.结果:治疗后现察组较对照组血压下降明显,尿量增加,孕周延长时间长,围产儿结局好,很大程度上缓解血液高凝状态.结论:低分子肝素钠在治疗重度子痫前期中治疗效果显著,在安全方面上能最大程度上保障母婴安全,值得临床推广.“,”objective: to study the low molecular heparin sodium for severe preeclampsia clinical curative effect observation effect.Methods: a retrospective in May 2010 to April 2012 to obstetrics and gynecology diagnosis and treatment of severe preeclampsia patients in 80 cases, 80 cases were randomly divided into two groups and an example. The observation group with low molecular heparin sodium 5000u abdominal subcutaneous injection; The comparison group USES the 25% magnesium sulfate and g static drop. Comparing the two groups before and after treatment of blood pressure and urine, 24 hours urinary protein content, gestational weeks extension of time, the function of blood coagulation, platelet count and postpartum amount of bleeding, evaluation of two groups of perinatal infants dead end and complications. Results: after treatment was relatively less than control group is low blood pressure, urine volume increase, gestational weeks extension of time long, blood coagulation function strengthen, perinatal infants dead end, between the two groups (P 0.05). Conclusion: low molecular heparin sodium in the treatment of severe preeclampsia in treatment effect significantly, in the comparison item are lowest, in terms of security to the maximum extent on the maternal and infant safety guarantee, it is worth clinical promotion.